Frankfurt
17.03.25 | 08:52
3,000 Euro
0,00 % 0,000
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | OPTHEA LIMITED: Quarterly Activities/Appendix 4C Cash Flow Report | - | ASX | ||
| Do | Opthea Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| Mi | OPTHEA LIMITED: Opthea announces intention to delist from Nasdaq | - | ASX | ||
| 27.10. | Opthea Appoints Hamish George As CFO | - | RTTNews | ||
| 26.10. | OPTHEA LIMITED: Appointment of Company Secretary and CFO | 1 | ASX | ||
| 15.10. | OPTHEA LIMITED: Long Term Suspended Entities | 1 | ASX | ||
| OPTHEA LIMITED ADR Aktie jetzt für 0€ handeln | |||||
| 09.10. | OPTHEA LIMITED: Notice of Annual General Meeting/Proxy Form | - | ASX | ||
| 06.10. | Opthea Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 06.10. | OPTHEA LIMITED: Opthea Receives A$10.8 million R&D Tax Incentive | 2 | ASX | ||
| 16.09. | OPTHEA LIMITED: Opthea - Annual General Meeting Date | 2 | ASX | ||
| 15.09. | Opthea Ltd - 20-F, Annual and transition report of foreign private issuers | 1 | SEC Filings | ||
| 15.09. | Opthea Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 15.09. | OPTHEA LIMITED: 2025 Corporate Governance Statement | - | ASX | ||
| 15.09. | OPTHEA LIMITED: Annual Report to shareholders | - | ASX | ||
| 05.09. | OPTHEA LIMITED: S&P DJI Announces September 2025 Quarterly Rebalance | 2 | ASX | ||
| 29.08. | Opthea Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 29.08. | OPTHEA LIMITED: Preliminary Final Report | - | ASX | ||
| 22.08. | OPTHEA LIMITED: Ceasing to be a substantial holder | 2 | ASX | ||
| 21.08. | OPTHEA LIMITED: Becoming a substantial holder | 1 | ASX | ||
| 20.08. | OPTHEA LIMITED: Corporate Update Investor Call | 1 | ASX |
1 2 Weiter >>
32 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CORE ONE LABS | 0,079 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 22.09.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 22.09.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 22.09.2025ISIN NameAU000000PEK2 PEAK... ► Artikel lesen | |
| PALATIN TECHNOLOGIES | - | - | Palatin Technologies, Inc.: Palatin Earns €5.5 Million ($6.5 Million) Milestone Payment in Retinal Disease Collaboration with Boehringer Ingelheim | Collaboration focused on developing potential first-in-class melanocortin receptor targeted treatment for patients with diabetic retinopathy, including diabetic... ► Artikel lesen | |
| COSCIENS BIOPHARMA | 2,120 | 0,00 % | COSCIENS Biopharma Inc. Reports Second Quarter 2025 Financial Results and Provides Strategic Initiatives Update | COSCIENS Board of Directors approves a plan to voluntarily delist from Nasdaq, while retaining the Company's listing on the TSX TORONTO, ONTARIO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma... ► Artikel lesen | |
| HALOZYME THERAPEUTICS | 56,72 | +0,32 % | Insights into Halozyme Therapeutics' Upcoming Earnings | ||
| AMYRIS | - | - | Amyris gains sole control of Brazilian fermentation facility | ||
| ABCELLERA BIOLOGICS | 4,820 | -0,10 % | Why Did AbCellera's Stock Jump Over 7% After Hours? | ||
| GLOW LIFETECH | 0,024 | 0,00 % | Glow Lifetech Corp.: Glow Lifetech Reduces Warrant Overhang by 20+ Million as Largest Shareholder Exercises $450k+ At-the-Money Warrants, Bolstering Balance Sheet | Toronto, Ontario--(Newsfile Corp. - October 28, 2025) - Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to announce that it has further strengthened its... ► Artikel lesen | |
| BIO-RAD LABORATORIES | 274,70 | -0,94 % | Why Bio-Rad Laboratories Stock Slipped by More Than 3% on Thursday | ||
| AVID BIOSERVICES | 12,100 | 0,00 % | Avid Bioservices Appoints Kenneth Bilenberg as CEO | ||
| BIOLINERX | 2,755 | +0,92 % | XFRA YP2: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| WHITEHAWK THERAPEUTICS | 2,060 | 0,00 % | Whitehawk Therapeutics, Inc.: Whitehawk Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights | MORRISTOWN, N.J., Aug. 7, 2025 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to... ► Artikel lesen | |
| MINERVA NEUROSCIENCES | 3,640 | +2,82 % | Minerva Neurosciences: NBC-Tipp wird zum Tenbagger! | Anfang des Monats berichteten wir über hohe Preissprünge bei der Aktie von Minerva Neurosciences. Jetzt ist klar: Das anfängliche Kursspektakel bei der Biotech-Empfehlung des No Brainer Club war lediglich... ► Artikel lesen | |
| APPLIED THERAPEUTICS | 1,070 | +5,06 % | Applied Therapeutics Provides Update Following Meeting with FDA | NEW YORK, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT) (the Company), a clinical-stage biopharmaceutical company dedicated to creating transformative treatments for... ► Artikel lesen | |
| OVID THERAPEUTICS | 1,230 | -1,60 % | Ovid Therapeutics Inc.: Ovid Therapeutics Announces Pricing of Private Placement Totaling up to $175 Million in Gross Proceeds | NEW YORK, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to developing small molecule medicines for brain conditions with significant... ► Artikel lesen | |
| GEOVAX LABS | 0,563 | 0,00 % | GeoVax Labs files to sell 11.9M shares of common stock for holders |
OPTHEA LIMITED ADR gehört der Branche Biotechnologie an. Der aktuelle Kurs liegt bei 3,000 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu OPTHEA LIMITED ADR finden Sie auf Wallstreet Online.